| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789326 | Practical Radiation Oncology | 2017 | 29 Pages |
Abstract
Although VMDWAT increased brain V5 and the treatment time compared with coVMAT, it significantly reduced the dose to the hippocampus and brain V10 to V50 and improved target conformity and homogeneity. VMDWAT could be a promising treatment technique for pituitary adenomas and craniopharyngiomas.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Megumi MD, Takashi MD, PhD, Kengo MD, PhD, Yuki MS, Mitsuhiro PhD, Nobutaka PhD, Hideaki MS, Masahiro MD, PhD,